Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?

Aliment Pharmacol Ther. 2005 Mar:21 Suppl 1:7-8, 21-4. doi: 10.1111/j.1365-2036.2004.02347.x.

Author

J Scheiman¹

Affiliation

¹ University of Michigan Medical Center, Ann Arbor, MI, USA.

PMID: 15755267
DOI: 10.1111/j.1365-2036.2004.02347.x

No abstract available

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Aspirin / administration & dosage*
Aspirin / adverse effects
Cardiovascular Diseases / prevention & control*
Colorectal Neoplasms / prevention & control
Esophageal Neoplasms / prevention & control
Gastrointestinal Diseases / chemically induced
Humans
Proton Pump Inhibitors*
Risk Factors

Substances

Anti-Inflammatory Agents, Non-Steroidal
Proton Pump Inhibitors
Aspirin